SynOx Therapeutics Revenue and Competitors

Dublin, IE

Location

#5175

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • SynOx Therapeutics's estimated annual revenue is currently $5.1M per year.(i)
  • SynOx Therapeutics's estimated revenue per employee is $189,444
  • SynOx Therapeutics's total funding is $136M.

Employee Data

  • SynOx Therapeutics has 27 Employees.(i)
  • SynOx Therapeutics grew their employee count by 35% last year.

SynOx Therapeutics's People

NameTitleEmail/Phone
1
SVP, Chief Commercial OfficerReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Commercial Officer (CCO)Reveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
VP, External Affairs and Business DevelopmentReveal Email/Phone
8
SVP, Finance and OperationsReveal Email/Phone
9
SVP Finance and OperationsReveal Email/Phone
10
Director QualityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M502%N/AN/A
#2
$5.1M3314%N/AN/A
#3
$44.8M289N/AN/AN/A
#4
$22.1M61-28%$325.9MN/A
#5
$5.1M330%N/AN/A
#6
$24.6M15910%N/AN/A
#7
$5.1M2735%$136MN/A
Add Company

What Is SynOx Therapeutics?

SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

keywords:N/A

$136M

Total Funding

27

Number of Employees

$5.1M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M27-43%N/A
#2
$4.3M2780%N/A
#3
$3.9M2717%N/A
#4
$6.8M27-4%N/A
#5
$3.8M2750%N/A